BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank79
3Y CAGR-7.3%
5Y CAGR+40.3%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-7.3%/yr
vs +81.3%/yr prior
5Y CAGR
+40.3%/yr
Recent deceleration
Acceleration
-88.6pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
5.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $78.87M | -19.9% |
| 2024 | $98.52M | -9.0% |
| 2023 | $108.24M | +9.2% |
| 2022 | $99.09M | +67.1% |
| 2021 | $59.29M | +308.9% |
| 2020 | $14.50M | +21.9% |
| 2019 | $11.89M | +29.6% |
| 2018 | $9.18M | +7.1% |
| 2017 | $8.56M | +32.0% |
| 2016 | $6.49M | - |